Genome-Wide Association Study on the Early-Phase Insulin Response to a Liquid Mixed Meal: Results From the NEO Study.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
12 2019
Historique:
received: 12 04 2019
accepted: 09 09 2019
pubmed: 21 9 2019
medline: 17 3 2020
entrez: 21 9 2019
Statut: ppublish

Résumé

Early-phase insulin secretion is a determinant of postprandial glucose homeostasis. In this study, we aimed to identify novel genetic variants associated with the early-phase insulin response to a liquid mixed meal by a genome-wide association study using a discovery and replication design embedded in the Netherlands Epidemiology of Obesity (NEO) study. The early-phase insulin response was defined as the difference between the natural logarithm-transformed insulin concentrations of the postprandial state at 30 min after a meal challenge and the fasting state (Δinsulin). After Bonferroni correction, rs505922 (β: -6.5% [minor allele frequency (MAF) 0.32,

Identifiants

pubmed: 31537524
pii: db19-0378
doi: 10.2337/db19-0378
doi:

Substances chimiques

ABO Blood-Group System 0
Blood Glucose 0
Insulin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2327-2336

Informations de copyright

© 2019 by the American Diabetes Association.

Auteurs

Ruifang Li-Gao (R)

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands r.li@lumc.nl.

Françoise Carlotti (F)

Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.

Renée de Mutsert (R)

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.

Astrid van Hylckama Vlieg (A)

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.

Eelco J P de Koning (EJP)

Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
University Medical Center Utrecht, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Utrecht, the Netherlands.
Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.

J Wouter Jukema (JW)

Einthoven Laboratory for Experimental Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, Netherlands.
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.

Frits R Rosendaal (FR)

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.

Ko Willems van Dijk (K)

Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.

Dennis O Mook-Kanamori (DO)

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH